Anti-Trust | Virginia Eastern

Memorandum in Opposition

Memorandum in Opposition re 1861 MOTION in Limine No. 24 to Exclude Statements Suggesting that the Glenmark and Mylan Cases Would Have Been Evaluated Differently at the Time of the Glenmark Settlement (on behalf of Merck and Glenmark Defendants) Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)

Anti-Trust | Virginia Eastern

Memorandum in Opposition

Memorandum in Opposition re 1858 MOTION in Limine No. 23 to Preclude Dr. McGuire from Testifying Regarding the Amount of Monetary Harm or Damages Suffered by Zetia Purchasers (on behalf of Merck and Glenmark Defendants) Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)

Anti-Trust | Virginia Eastern

Memorandum in Opposition

Memorandum in Opposition re 1855 MOTION in Limine No. 22 to Preclude Drs. McGuire and Leffler from Opining, and Plaintiffs from Arguing, that their Valuations of the Challenged Provision Accounted for Merck's Right to Launch a Second Branded Ezetimibe Product (on behalf of Me Memorandum in Opposition filed on behalf of Purchasers filed by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, Cardinal Health P.R. 120, Inc., Cardinal Health, Inc., FWK Holdings, LLC, H.D. Smith, LLC, KPH Healthcare Services, Inc., MLI RX, LLC, McKesson Corporation, Meijer Distribution, Inc., Meijer, Inc., Rochester Drug Cooperative, Inc., on behalf of itself and all others similarly situated, SUPERVALU, Inc., Smith Medical Partners, LLC, The Harvard Drug Group, L.L.C., Valley Wholesale Drug Company, LLC, Wegmans Food Markets, Inc.. (Monroe, William)